Conference abstractPublished 25 Nov 2019
WNT5A and IL10 in obese patients with insulin resistance
Immanuel Kant Baltic Federal University, Russia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The anti-inflammatory cytokine interleukin-10 (IL10) may play a protective role in type 2 diabetes (T2D). The Wnt5a signaling pathway regulates the production of a wide range of cytokines in stellate cells of the liver, so we suggest a relationship between the expression of the WNT5a gene in the liver and the content of IL-10 in the circulation in obese patients with and without T2D. Methodology & Theoretical Orientation: Serum glucose levels were determined on a biochemical analyzer; the concentration of IL10 in blood plasma - by flow fluorimetry; WNT5a gene expression level - by PCR; quantitative content of protein WNT5A – by Western Blotting. Findings: Expression of the gene Wnt5a in the group of obese patients without diabetes increased by 1.7 times (p<0.05); the group of obese patients with diabetes increased by 1.47 times (p<0.05). Liver protein Wnt5a levels consistent with gene expression Wnt5a. Plasma blood IL10 levels in patients with type 2 diabetes were lower than in patients without type 2 diabetes [1]. Pereira C. et al. was found the inhibitory effect of Wnt5a overexpression on the anti-inflammatory cytokine IL10 in a culture of isolated macrophages and a decreased in the release of pro-inflammatory cytokines [1]. While a low IL10 concentration in blood plasma can contribute to the development of chronic inflammation in patients with T2D [2]. The level of IL10 negatively correlated with the level of expression of the WNT5a gene in the liver in patients with type 2 diabetes (r=-0,548, р<0.05). High expression of WNT5A in the liver was associated with a high IL10 plasma level in patients with obesity without type 2 diabetes and a low IL10 plasma level in patients with obesity with type 2 diabetes. Conclusion & Significance: Thus, a high level of WNT5a gene expression can be associated with the protective effect of IL 10 in obese patients without T2D.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Komar Aleksandra”